The UK plans to offer alternatives to AstraZeneca's COVID-19 vaccine to people under the age of 30. Officials say a suspected blood-clot side effect is rare and the jab's benefits outweigh any risks. But young people are thought to face the highest risk of clots and lowest risk from COVID-19. The chart above, made by the UK Medicines and Healthcare products Regulatory Agency, estimates this balance of risks.
Next